Cost-effectiveness of prenatal screening strategies for congenital heart disease

Ultrasound in Obstetrics and Gynecology

Volumn 44, Issue 1, 2014, Pages 50-57

  Pinto, N M ^a   Nelson, R ^a   Puchalski, M ^a   Metz, T D ^a   Smith, K J ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

congenital heart disease; cost; cost analysis; nuchal translucency measurement; prenatal diagnosis; prenatal ultrasound

Indexed keywords

CONGENITAL HEART MALFORMATION; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ECONOMICS; EVALUATION STUDY; FEMALE; FETUS ECHOGRAPHY; HEALTH CARE COST; HUMAN; MONTE CARLO METHOD; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PROCEDURES; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE COSTS; HEART DEFECTS, CONGENITAL; HUMANS; MONTE CARLO METHOD; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UNITED STATES;

EID: 84903770080     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.13287     Document Type: Article

References (56)

1. Hoffman JI,. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol 1995; 16: 155-165.
2. Kleinert S., Routine prenatal screening for congenital heart disease. Lancet 1996; 348: 836.
3. Stumpflen I, Stumpflen A, Wimmer M, Bernaschek G,. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996; 348: 854-857.
4. AIUM Practice Guideline for the Performance of Obstetric Ultrasound Examinations. J Ultrasound Med 2013; 32: 1083-1101.
5. AIUM Practice Guideline for the Performance of Obstetric Ultrasound Examinations. J Ultrasound Med 2010; 29: 157-166.
6. American College of Radiology Practice Guideline for the Performance of Obstetrical Ultrasound. American College of Radiology: Reston, VA, 2007.
7. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
8. Cargill Y, Morin L,. Content of a complete routine second trimester obstetric ultrasound examination and report. J Obstet Gynaecol Can 2009; 31: 272-275.
9. National Institute for Health and Clinical Excellence. Antenatal Care: Routine Care for the Healthy Pregnant Woman. NICE: London, 2008.
10. Bromley B, Estroff JA, Sanders SP, Parad R, Roberts D, Frigoletto FD Jr, Benacerraf BR,. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol 1992; 166: 1473-1481.
11. Chew C, Halliday JL, Riley MM, Penny DJ,. Population-based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound Obstet Gynecol 2007; 29: 619-624.
12. Khoo NS, Van Essen P, Richardson M, Robertson T,. Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999-2003. Aust N Z J Obstet Gynaecol 2008; 48: 559-563.
13. Stoll C, Garne E, Clementi M,. Evaluation of prenatal diagnosis of associated congenital heart diseases by fetal ultrasonographic examination in Europe. Prenat Diagn 2001; 21: 243-252.
14. Marek J, Tomek V, Skovranek J, Povysilova V, Samanek M,. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience. Heart 2011; 97: 124-130.
15. McBrien A, Sands A, Craig B, Dornan J, Casey F,. Major congenital heart disease: antenatal detection, patient characteristics and outcomes. J Matern Fetal Neonatal Med 2009; 22: 101-105.
16. Pinto NM, Keenan HT, Minich LL, Puchalski MD, Heywood M, Botto LD,. Barriers to prenatal detection of congenital heart disease: a population-based study. Ultrasound Obstet Gynecol 2012; 40: 418-425.
17. Makrydimas G, Sotiriadis A, Ioannidis JP,. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 2003; 189: 1330-1335.
18. Clur SA, Ottenkamp J, Bilardo CM,. The nuchal translucency and the fetal heart: a literature review. Prenat Diagn 2009; 29: 739-748.
19. Cohen L, Mangers K, Grobman WA, Gotteiner N, Julien S, Dungan J, Fonseca L, Platt LD,. Three-dimensional fast acquisition with sonographically based volume computer-aided analysis for imaging of the fetal heart at 18 to 22 weeks' gestation. J Ultrasound Med 2010; 29: 751-757.
20. Espinoza J, Lee W, Comstock C, Romero R, Yeo L, Rizzo G, Paladini D, Viñals F, Achiron R, Gindes L, Abuhamad A, Sinkovskaya E, Russell E, Yagel S,. Collaborative study on 4-dimensional echocardiography for the diagnosis of fetal heart defects: the COFEHD study. J Ultrasound Med 2010; 29: 1573-1580.
21. Odibo AO, Coassolo KM, Stamilio DM, Ural SH, Macones GA,. Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies. Prenat Diagn 2006; 26: 39-44.
22. Mistry H, Gardiner HM,. The cost-effectiveness of prenatal detection for congenital heart disease using telemedicine screening. J Telemed Telecare 2013; 19: 190-196.
23. Papatheodorou SI, Evangelou E, Makrydimas G, Ioannidis JP,. First-trimester ductus venosus screening for cardiac defects: a meta-analysis. BJOG 2011; 118: 1438-1445.
24. Cardiac screening examination of the fetus: guidelines for performing the 'basic' and 'extended basic' cardiac scan. Ultrasound Obstet Gynecol 2006; 27: 107-113.
25. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120: 1532-1534.
26. Benn P, Cuckle H, Pergament E,. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013; 42: 15-33.
27. Bernard LS, Ramos GA, Fines V, Hull AD,. Reducing the cost of detection of congenital heart disease in fetuses of women with pregestational diabetes mellitus. Ultrasound Obstet Gynecol 2009; 33: 676-682.
28. Tegnander E, Eik-Nes SH,. The examiner's ultrasound experience has a significant impact on the detection rate of congenital heart defects at the second-trimester fetal examination. Ultrasound Obstet Gynecol 2006; 28: 8-14.
29. McBrien A, Sands A, Craig B, Dornan J, Casey F,. Impact of a regional training program in fetal echocardiography for sonographers on the antenatal detection of major congenital heart disease. Ultrasound Obstet Gynecol 2010; 36: 279-284.
30. Friedberg MK, Silverman NH, Moon-Grady AJ, Tong E, Nourse J, Sorenson B, Lee J, Hornberger LK,. Prenatal detection of congenital heart disease. J Pediatr 2009; 155: 26-31, e1.
31. Jegatheeswaran A, Oliveira C, Batsos C, Moon-Grady AJ, Silverman NH, Hornberger LK, Coyte P, Friedberg MK,. Costs of prenatal detection of congenital heart disease. Am J Cardiol 2011; 108: 1808-1814.
32. Grosse SD,. Assessing cost-effectiveness in healthcare: history of the 50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008; 8: 165-178.
33. Gekas J, Durand A, Bujold E, Vallée M, Forest JC, Rousseau F, Reinharz D,. Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used? Am J Obstet Gynecol 2011; 204: 175, e1-e8.
34. Cunningham GC, Tompkinison DG,. Cost and effectiveness of the California triple marker prenatal screening program. Genet Med 1999; 1: 199-206.
35. Hoogendoorn M, Evers SM, Schielen PC, van Genugten ML, de Wit GA, Ament AJ,. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects. Community Genet 2008; 11: 359-367.
36. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J,; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215.
37. Copel JA, Tan AS, Kleinman CS,. Does a prenatal diagnosis of congenital heart disease alter short-term outcome? Ultrasound Obstet Gynecol 1997; 10: 237-241.
38. Yount LE, Mahle WT,. Economic analysis of palivizumab in infants with congenital heart disease. Pediatrics 2004; 114: 1606-1611.
39. Ganiats TG,. Justifying prenatal screening and genetic amniocentesis programs by cost-effectiveness analyses: a re-evaluation. Med Decis Making 1996; 16: 45-50.
40. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L,. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007; 115: 163-172.
41. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD,. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001; 103: 2376-2381.
42. Botto LD, Correa A, Erickson JD,. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001; 107: E32.
43. Garne E, Stoll C, Clementi M,. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001; 17: 386-391.
44. Nikkila A, Bjorkhem G, Kallen B,. Prenatal diagnosis of congenital heart defects-a population based study. Acta Paediatr 2007; 96: 49-52.
45. Sklansky MS, Berman DP, Pruetz JD, Chang RK,. Prenatal screening for major congenital heart disease: superiority of outflow tracts over the 4-chamber view. J Ultrasound Med 2009; 28: 889-899.
46. Acherman RJ, Evans WN, Luna CF, Rollins R, Kip KT, Collazos JC, Restrepo H, Adasheck J, Iriye BK, Roberts D, Sacks AJ,. Prenatal detection of congenital heart disease in southern Nevada: the need for universal fetal cardiac evaluation. J Ultrasound Med 2007; 26: 1715-1719; quiz 20-21.
47. Vergani P, Mariani S, Ghidini A, Schiavina R, Cavallone M, Locatelli A, Strobelt N, Cerruti P,. Screening for congenital heart disease with the four-chamber view of the fetal heart. Am J Obstet Gynecol 1992; 167: 1000-1003.
48. Achiron R, Glaser J, Gelernter I, Hegesh J, Yagel S,. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. BMJ 1992; 304: 671-674.
49. Ogge G, Gaglioti P, Maccanti S, Faggiano F, Todros T,. Prenatal screening for congenital heart disease with four-chamber and outflow-tract views: a multicenter study. Ultrasound Obstet Gynecol 2006; 28: 779-784.
50. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B,. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002; 88: 387-391.
51. Friedman AM, Phoon CK, Fishman S, Seubert DE, Timor-Tritsch IE, Schwartz N,. The utility of fetal echocardiography after an unremarkable anatomy scan. Obstet Gynecol 2011; 118: 921-927.
52. Starikov RS, Bsat FA, Knee AB, Tsirka AE, Paris Y, Markenson GR,. Utility of fetal echocardiography after normal cardiac imaging findings on detailed fetal anatomic ultrasonography. J Ultrasound Med 2009; 28: 603-608.
53. Muller PR, James A, Feldman K, Herlong JR,. Utility of fetal echocardiogram in high-risk patients. Aust N Z J Obstet Gynaecol 2005; 45: 117-121.
54. Mavrides E, Cobian-Sanchez F, Tekay A, Moscoso G, Campbell S, Thilaganathan B, Carvalho JS,. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001; 17: 106-110.
55. Meyer-Wittkopf M, Cooper S, Sholler G,. Correlation between fetal cardiac diagnosis by obstetric and pediatric cardiologist sonographers and comparison with postnatal findings. Ultrasound Obstet Gynecol 2001; 17: 392-397.
56. Physician Fee Schedule. www.cms.gov/physician-fee-schedule/search/. Centers for Medicare and Medicaid Services, Baltimore, MD (last updated 17 April 2014).